Showing results (11-20 of 52) with videos related to
Sort By:
Pageof 6
Pediatric Blood & Cancer|December 1, 2020
Derivation and validation of risk groups in patients with osteosarcoma utilizing regression tree analysisLenka A Ilcisin, Clement Ma, Katherine A Janeway, et al.Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|January 14, 2021
Facial Paralysis From Post-transplant Lymphoproliferative DisorderJoonas Toivonen, David S Shulman, Suzanne Shusterman, et al.Pediatric Blood & Cancer|September 5, 2020
Landscape of phase 1 clinical trials for minors with cancer in the United StatesJaclynne H Nader, Dylan V Neel, David S Shulman, et al.Cancer Medicine|December 16, 2024
Statistical Fragility of Findings From Randomized Phase 3 Trials in Pediatric OncologyHannah E Olsen, Pei-Chi Kao, Caleb Richmond, et al.Cancer Medicine|June 7, 2022
Derivation and validation of a risk classification tree for patients with synovial sarcomaDylan V Neel, Clement Ma, Natalie B Collins, et al.Journal of Adolescent and Young Adult Oncology|November 21, 2025
Disrupted Independence-Supporting Adolescents and Young Adults with Sarcoma in Maintaining Autonomy: A Qualitative StudyVinayak Venkataraman, Bridgette Merriman, Anna Revette, et al.The Oncologist|June 24, 2025
Effect of HLA restriction on racial and ethnic disparities in access to immune therapies for advanced synovial sarcomaVinayak Venkataraman, Hannah R Abrams, David S Shulman, et al.Cancer Medicine|April 17, 2024
Off-label prescribing of immune checkpoint inhibitor therapy at a single pediatric cancer centerAjami Gikandi, Susan N Chi, Kee Kiat Yeo, et al.Cancer Medicine|August 5, 2020
Off-label prescribing of targeted anticancer therapy at a large pediatric cancer centerMir Lim, David S Shulman, Holly Roberts, et al.Pediatric Blood & Cancer|August 30, 2023
Evaluation of prevalence and outcomes of serial tyrosine kinase inhibitor use in pediatric patients with advanced solid tumorsHannah E Olsen, Kevin X Liu, A Lindsay Frazier, et al.Pageof 6